Contact us
Log in
Dr. Tevita Aho, MD

Overview

Dr Tevita Aho moved from New Zealand to the UK to be the Clinical Fellow in Uro-oncology at Cambridge University Hospitals NHS Foundation Trust (CUH) in 2003. The following year he was appointed as a Consultant Urological Surgeon.

During his training in NZ he spent a year learning Holmium Laser Enucleation of the Prostate (HoLEP) from the urologists who invented it. In 2004, Mr Aho introduced HoLEP at CUH where it rapidly became, and remains, the treatment of choice for the majority of men seeking a surgical treatment for urinary symptoms or retention. CUH was one of the first centres in the UK to offer HoLEP.

Mr Aho is the most experienced HoLEP surgeon in the UK, and has performed more than 1,700 procedures. He is frequently invited to lecture on HoLEP in the UK and abroad and has convened 13 annual HoLEP courses at CUH, where hundreds of delegates have learned how to perform HoLEP. He has demonstrated live laser prostate surgery (including the world’s first thulium laser enucleation of the prostate) on more than 25 occasions at conferences throughout the world.

He also has experience with other forms of benign prostate surgery including laser vaporisation and the minimally invasive urolift procedure. Mr Aho is the founding President of the UK Holmium User Group (HUG). He designed and implemented the national HUG Training Programme for HoLEP (a model which is now used internationally), and has mentored many surgeons in HoLEP. Mr Aho has been involved in HoLEP research from its earliest days, and has published and presented widely on the subject.

Cambridge, United Kingdom
Urology
English

Work Experience

Partner
Since 2008
The Cambridge Urology Partnership UK
Consultant Urological Surgeon The Harley Street Clinic Diagnostic Centre
Since 2005
HCA, Princess Grace Hospital, Marylebone, London, UK
Consultant Urological Surgeon
Since 2005
Spire Cambridge Lea Hospital, Cambridge, UK

Education

Fellowship, Uro-oncology
2003 to 2004
Cambridge University Hospital, NHS Foundation Trust, (CUH), UK
BHB, MBCHB, Medicine
1989 to 1994
University of Aukland, New Zealand

Pubmed

Spatiotemporal immune zonation of the human kidney.
2019
Science (New York, N.Y.) Read it here Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained.
2019
Advances in therapy Read it here Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes.
2019
Urology Read it here

Professional Associations

UK Holmium User Group (HUG) Founder & President